Associated Papers
Identification of osimertinib-resistant EGFR L792 mutations by cfDNA sequencing: oncogenic activity assessment and prevalence in large cfDNA cohort.
Fairclough SR et al.
Experimental Hematology & Oncology, 2019
Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature.
Klempner SJ et al.
Lung Cancer (auckland, N.z.), 2017
Select a paper to view details